Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04541108
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2020-09-01
Brief Title:
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Sponsor:
Presage Biosciences
Organization:
Presage Biosciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| soft tissue sarcoma | View |
| HNSCC | View |
| SCCHN | View |
| lymphoma | View |
| sarcoma | View |
| breast adenocarcinoma | View |
| melanoma | View |
| intratumoral microdosing | View |
| microdose injection | View |
| microdosing | View |
| in vivo oncology | View |
| in vivo drug sensitivity | View |
| tumor microenvironment | View |
| multiplexed immunohistochemistry | View |
| head and neck cancer | View |
| pharmacodynamic biomarkers | View |
| CIVO | View |
| master protocol | View |
| precision oncology | View |